CDDF & WECAN Foundation: Memorandum of Understanding
🔔 📢 We are delighted to announce that CDDF and the WECAN Foundation (Workgroup of European Cancer Patient Advocacy Networks) have formalized our long-standing collaboration through a Memorandum of Understanding. This partnership will enable the organizations to work...
![[🔔 📊 Participate in the ENCePP Survey on AI in Pharmacoepidemiology & Pharmacovigilance]](https://cddf.org/wp-content/uploads/2026/07/Capture-400x250.jpg)
[🔔 📊 Participate in the ENCePP Survey on AI in Pharmacoepidemiology & Pharmacovigilance]
The ENCePP Working Group on Artificial Intelligence in Pharmacoepidemiology and Pharmacovigilance invite stakeholders to contribute to a survey examining the perception and use of artificial intelligence (AI) tools across Pharmacoepidemiology (PE) and...
![📢 🔔 [News from EMA – Public Consultation on Its Draft Recommendations]](https://cddf.org/wp-content/uploads/2026/07/EMA-News-5-400x250.jpg)
📢 🔔 [News from EMA – Public Consultation on Its Draft Recommendations]
The European Network of Paediatric Research at the EMA (EnprEMA) has launched a public consultation on its draft recommendations: "Cross-border access to paediatric clinical trials in Europe: preventing language exclusion." 📄 About the draft recommendations The draft...
🔔 Meeting of Interest in Cancer Drug Development: 2026 AAADV Workshop
Registration is NOW OPEN for the 2026 AAADV Workshop! 📅 Date: November 5–6, 2026 📍 Location: North Bethesda Marriott Hotel & Conference Center (In-Person & Virtual Participation Available) 📝 View the draft program: https://aaadv.org/2026-aaadv-workshop-agenda/...
ACT EU Multi-Stakeholder Platform: Meeting Documents from 18 June 2026
The meeting documents from ACT-EU MSP meeting held on 18 June 2026 are available now on the ACT EU website. These include presentations from the European Commission on Progress with the BioTech Act and specifically its clinical trial related aspects - present by C....
Report on the ACT EU Webinar Regarding Contractual Agreements
The report on the ACT EU webinar regarding contractual agreements, held on 16 April, has been published on the ACT EU website. The webinar explored how clinical site agreements affect the start-up of clinical trials and shared national and European experiences on...
Final: ICH E6(R3) GCP Annex 2
📢 ICH E6(R3) GCP Annex 2 was finalized and published by ICH on 3 June 2026. It covers pragmatic and decentralized elements, as well as the use of real-world data (RWD)—topics frequently discussed in CDDF meetings. The guidance also offers valuable insights into...
Key Takeaways from CDDF Live Webinar Series – “AI and Big Data AI in Drug Development: Transparency and Risk Assessment” (16 June 2026)
The CDDF is pleased to share the key takeaways from our live webinar series – “AI and Big Data AI in Drug Development: Transparency and Risk Assessment” held on 16 June 2026. This webinar included a lecture by Dr. Weida Tong (FDA) followed by a 30-minute Q&A...
![[MESSAGE FROM ACT EU – Request for stakeholders’ input on the guideline to simplify the clinical trials application package for use during Public Health Emergencies (PHEs).]](https://cddf.org/wp-content/uploads/2026/06/Copy-of-PUBLICATION-Annual-Repport-2024-Is-available-6-400x250.jpg)
[MESSAGE FROM ACT EU – Request for stakeholders’ input on the guideline to simplify the clinical trials application package for use during Public Health Emergencies (PHEs).]
ACT EU has developed the guideline to simplify the clinical trials application package for use during PHEs. The package consists of: 1️⃣ A guidance document on the simplified application package for clinical trials targeting a PHE 2️⃣ Annex I: Part I language...